Lupa Kata Sandi? Klik di Sini

atau Masuk melalui

Belum Memiliki Akun Daftar di Sini


atau Daftar melalui

Sudah Memiliki Akun Masuk di Sini

Konfirmasi Email

Kami telah mengirimkan link aktivasi melalui email ke rudihamdani@gmail.com.

Klik link aktivasi dan dapatkan akses membaca 2 artikel gratis non Laput di koran dan Majalah Tempo

Jika Anda tidak menerima email,
Kirimkan Lagi Sekarang

Tempo English
Support Tempo
LOGIN REGISTER
image-bahasa
image-language

Bio Farma To Receive Rp2 Trillion in State Capital Injections

Translator

Ricky Mohammad Nugraha

Editor

Markus Wisnu Murti

6 November 2020 20:50 WIB

Bio Farma logo. Bumn.go.id

TEMPO.CO, Jakarta - The Finance Ministry is set to disburse state capital injections (PMN) worth Rp2 trillion to state pharmaceutical firm Bio Farma by the end of this year. This was revealed by the Finance Ministry’s Director General of State Wealth Isa Rachmatarwata. 

“If it’s possible we can add it to the 2020 state budget plan (APBN) because it is relevant to the handling of the COVID-19 pandemic. There are only 2 months left but I guess that would be enough for us to manage,” said Isa in Friday’s virtual discussion. 

Isa added the discussion with the House of Representatives (DPR) budget committee (Banggar) sparked the idea of increasing the capital injections for Bio Farma Group, which has now become a holding. 

The capital injections will reportedly be used to construct facilities for medications and vaccine production.

Read: Bio Farma To Clinically Test Red and White COVID-19 Vaccine

HENDARTYO HANGGI

Bio FarmaPMN


Recommended

Bio Farma, MSD to Launch NusaGard Cervix Cancer Vaccines in Indonesia

2 Agustus 2023

Bio Farma, MSD to Launch NusaGard Cervix Cancer Vaccines in Indonesia

Bio Farma collaborates with MSD to launch NusaGard vaccines, the domestically produced human papillomavirus (HPV) vaccine.


Bio Farma 'Post-Covid' Earnings Slump 50 Percent in 2022

21 Juni 2023

Bio Farma 'Post-Covid' Earnings Slump 50 Percent in 2022

The consolidated earnings logged by Bio Farma nosedived to Rp21.54 trillion in 2022, which is a 50.4 percent drop.


Indonesia's Bio Farma Sends 1.5 Million Pentavalent Vaccines to Nigeria

30 Mei 2023

Indonesia's Bio Farma Sends 1.5 Million Pentavalent Vaccines to Nigeria

Bio Farma on Tuesday sent 1.5 million pentavalent vaccine doses under the Pentabio trade brand to Nigeria.


Indonesia's Bio Farma Opens Vaccine Technology Transfer with Ghana

21 Mei 2023

Indonesia's Bio Farma Opens Vaccine Technology Transfer with Ghana

Indonesia's pharmaceutical company PT Bio Farma has opened the opportunity for vaccine technology transfer with the Republic of Ghana, West Africa


Bio Farma and MSD Partner Up in Local HPV Vaccine Production

15 Mei 2023

Bio Farma and MSD Partner Up in Local HPV Vaccine Production

Bio Farma received the technical vision from Merck Sharp Dohme (MSD) in the development of locally-produced Human Papillomavirus (HPV) vaccine.


Bio Farma Aims to Make IndoVac as COVID-19 Multi-strain Vaccine

22 Januari 2023

Bio Farma Aims to Make IndoVac as COVID-19 Multi-strain Vaccine

PT Bio Farma is aiming to make its COVID-19 vaccine, IndoVac, a multi-strain vaccine after the COVID-19 pandemic subsides.


Legislator Laments Jakarta-Bandung High-Speed Rail's Capital Injection

11 Januari 2023

Legislator Laments Jakarta-Bandung High-Speed Rail's Capital Injection

DPR member Suryadi Jaya laments the government's state capital injections for the Jakarta-Bandung High-Speed Rail cost overrun.


Garuda Indonesia Obtains Rp7.5 Trillion State Capital Injection

20 Desember 2022

Garuda Indonesia Obtains Rp7.5 Trillion State Capital Injection

Flag carrier Garuda Indonesia officially received an Rp7.5 trillion state capital injection or PMN on Tuesday.


Jokowi Launches Homegrown COVID-19 Vaccine Indovac

13 Oktober 2022

Jokowi Launches Homegrown COVID-19 Vaccine Indovac

President Jokowi officially launches a homegrown COVID-19 vaccine named IndoVac, produced by state-owned pharmacy Bio Farma in Bandung.


Erick Thohir Claims Domestic Vaccine Indovac Has High Efficacy, Halal

2 September 2022

Erick Thohir Claims Domestic Vaccine Indovac Has High Efficacy, Halal

SOE Minister Erick Thohir disclosed that based on the clinical trial, homegrown COVID-19 vaccine developed by Bio Farma, Indovac, has high efficacy.